Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the endocrine system (HP:0000818)help
Parent Node:
expand
Abnormal circulating hormone concentration (HP:0003117)help
..Starting node
..expand
Abnormal circulating adrenocorticotropin concentration (HP:0011043)help
Term ID: 11043
Name: Abnormal circulating adrenocorticotropin concentration
Synonym: Abnormality of circulating ACTH level; Abnormality of circulating adrenocorticotropic hormone level; Abnormality of circulating adrenocorticotropin level; Abnormality of circulating corticotropin level
Definition: An abnormal concentration of corticotropin in the blood.
Comments:
Reference: HP:0011043
Genes and Diseases:
 
       Child Nodes:
........expandDecreased circulating ACTH level (HP:0002920) help
........expandIncreased circulating ACTH level (HP:0003154) help

 Sister Nodes: 
..expandAbnormal adiponectin level (HP:0030684) help
..expandAbnormal circulating androgen level (HP:0030347) help
..expandAbnormal circulating antimullerian hormone concentration (HP:0031101) help
..expandAbnormal circulating estrogen level (HP:0025132) help
..expandAbnormal circulating gonadotropin concentration (HP:0030338) help
..expandAbnormal circulating inhibin level (HP:0031099) help
..expandAbnormal circulating insulin concentration (HP:0040214) help
..expandAbnormal circulating leptin concentration (HP:0004361) help
..expandAbnormal circulating osteocalcin level (HP:0031427) help
..expandAbnormal circulating pregnenolone concentration (HP:0031187) help
..expandAbnormal circulating progesterone level (HP:0031212) help
..expandAbnormal circulating thyroid hormone concentration (HP:0031508) help
..expandAbnormal glucagon level (HP:0030687) help
..expandAbnormal gonadotropin-releasing hormone concentration (HP:0500012) help
..expandAbnormal serum insulin-like growth factor 1 level (HP:0030352) help
..expandAbnormality of circulating catecholamine level (HP:0012099) help
..expandAbnormality of circulating glucocorticoid level (HP:0012111) help
..expandDecreased circulating dehydroepiandrosterone concentration (HP:0031214) help
..expandDecreased circulating dehydroepiandrosterone-sulfate concentration (HP:0031215) help
..expandDecreased circulating parathyroid hormone level (HP:0031817) help
..expandDecreased response to growth hormone stimulation test (HP:0000824) help
..expandElevated circulating parathyroid hormone level (HP:0003165) help
..expandElevated vascular endothelial growth factor level (HP:0031052) help
..expandFasting hypoglycemia (HP:0003162) help
..expandIncreased pituitary glycoprotein hormone alpha subunit level (HP:0031208) help
..expandIncreased serum serotonin (HP:0003144) help
..expandobsolete Increased serum 1,25-dihydroxyvitamin D3 (HP:0003152) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic95
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0ARMC5 CL E G H7979825781OMIM:615954ACTH-independent macronodular adrenal hyperplasia 27
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomach169
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency31
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency31
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency112
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomach
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0FOXA2 CL E G H31705022ORPHA:95494Combined pituitary hormone deficiencies, genetic forms
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0GLI2 CL E G H27364318ORPHA:95494Combined pituitary hormone deficiencies, genetic forms173
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia101
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0HESX1 CL E G H88204877ORPHA:95494Combined pituitary hormone deficiencies, genetic forms21
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function21
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function51
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0LHX4 CL E G H8988421734ORPHA:95494Combined pituitary hormone deficiencies, genetic forms43
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function43
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0MC2R CL E G H41586930ORPHA:361Familial glucocorticoid deficiencyHP:0040281 - Very frequent94
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0MC2R CL E G H41586930OMIM:202200Glucocorticoid deficiency 194
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0MRAP CL E G H562461304ORPHA:361Familial glucocorticoid deficiencyHP:0040281 - Very frequent26
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0MRAP CL E G H562461304OMIM:607398Glucocorticoid deficiency 226
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndrome11
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0NNT CL E G H235307863ORPHA:361Familial glucocorticoid deficiencyHP:0040281 - Very frequent13
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndrome79
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0OTX2 CL E G H50158522ORPHA:95494Combined pituitary hormone deficiencies, genetic forms41
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 213
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0POR CL E G H54479208OMIM:201750Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis76
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency76
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0POR CL E G H54479208OMIM:613571Disordered steroidogenesis due to cytochrome P450 oxidoreductase76
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0POU1F1 CL E G H54499210ORPHA:95494Combined pituitary hormone deficiencies, genetic forms36
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function36
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1134
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PROP1 CL E G H56269455ORPHA:95494Combined pituitary hormone deficiencies, genetic forms54
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or function54
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0PROP1 CL E G H56269455ORPHA:90695Non-acquired panhypopituitarism54
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0SOX3 CL E G H665811199ORPHA:90695Non-acquired panhypopituitarism24
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0STAR CL E G H677011359ORPHA:361Familial glucocorticoid deficiencyHP:0040281 - Very frequent45
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0TXNRD2 CL E G H1058718155ORPHA:361Familial glucocorticoid deficiencyHP:0040281 - Very frequent85
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011043HP:0011043Abnormal circulating adrenocorticotropin concentration0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic7
HP:0011043HP:0003154Increased circulating ACTH level1AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0011043HP:0002920Decreased circulating ACTH level1AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040282 - Frequent95
HP:0011043HP:0002920Decreased circulating ACTH level1AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0011043HP:0002920Decreased circulating ACTH level1ARMC5 CL E G H7979825781OMIM:615954ACTH-independent macronodular adrenal hyperplasia 27
HP:0011043HP:0002920Decreased circulating ACTH level1ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011043HP:0003154Increased circulating ACTH level1ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011043HP:0003154Increased circulating ACTH level1ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomachHP:0040284 - Very rare169
HP:0011043HP:0002920Decreased circulating ACTH level1BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0011043HP:0003154Increased circulating ACTH level1BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011043HP:0003154Increased circulating ACTH level1CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011043HP:0002920Decreased circulating ACTH level1CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040282 - Frequent636
HP:0011043HP:0002920Decreased circulating ACTH level1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0011043HP:0003154Increased circulating ACTH level1CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0011043HP:0003154Increased circulating ACTH level1CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040281 - Very frequent31
HP:0011043HP:0003154Increased circulating ACTH level1CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040282 - Frequent112
HP:0011043HP:0003154Increased circulating ACTH level1DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomachHP:0040284 - Very rare
HP:0011043HP:0002920Decreased circulating ACTH level1FOXA2 CL E G H31705022ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent
HP:0011043HP:0002920Decreased circulating ACTH level1GLI2 CL E G H27364318ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent173
HP:0011043HP:0002920Decreased circulating ACTH level1GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0011043HP:0002920Decreased circulating ACTH level1GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011043HP:0002920Decreased circulating ACTH level1HESX1 CL E G H88204877ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent21
HP:0011043HP:0002920Decreased circulating ACTH level1HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional21
HP:0011043HP:0002920Decreased circulating ACTH level1LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional51
HP:0011043HP:0002920Decreased circulating ACTH level1LHX4 CL E G H8988421734ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent43
HP:0011043HP:0002920Decreased circulating ACTH level1LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional43
HP:0011043HP:0003154Increased circulating ACTH level1MC2R CL E G H41586930OMIM:202200Glucocorticoid deficiency 1.94
HP:0011043HP:0002920Decreased circulating ACTH level1MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040282 - Frequent462
HP:0011043HP:0003154Increased circulating ACTH level1MRAP CL E G H562461304OMIM:607398Glucocorticoid deficiency 2.26
HP:0011043HP:0002920Decreased circulating ACTH level1NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0011043HP:0002920Decreased circulating ACTH level1NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndromeHP:0040281 - Very frequent11
HP:0011043HP:0003154Increased circulating ACTH level1NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011043HP:0003154Increased circulating ACTH level1NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040281 - Very frequent79
HP:0011043HP:0002920Decreased circulating ACTH level1OTX2 CL E G H50158522ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent41
HP:0011043HP:0002920Decreased circulating ACTH level1OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0011043HP:0002920Decreased circulating ACTH level1PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0011043HP:0002920Decreased circulating ACTH level1PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011043HP:0002920Decreased circulating ACTH level1PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011043HP:0002920Decreased circulating ACTH level1PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0011043HP:0002920Decreased circulating ACTH level1PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0011043HP:0003154Increased circulating ACTH level1POR CL E G H54479208OMIM:201750Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis.76
HP:0011043HP:0003154Increased circulating ACTH level1POR CL E G H54479208ORPHA:95699Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyHP:0040282 - Frequent76
HP:0011043HP:0003154Increased circulating ACTH level1POR CL E G H54479208OMIM:613571Disordered steroidogenesis due to cytochrome P450 oxidoreductase.76
HP:0011043HP:0002920Decreased circulating ACTH level1POU1F1 CL E G H54499210ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent36
HP:0011043HP:0002920Decreased circulating ACTH level1POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional36
HP:0011043HP:0002920Decreased circulating ACTH level1PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011043HP:0002920Decreased circulating ACTH level1PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0011043HP:0002920Decreased circulating ACTH level1PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011043HP:0002920Decreased circulating ACTH level1PROP1 CL E G H56269455ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent54
HP:0011043HP:0002920Decreased circulating ACTH level1PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional54
HP:0011043HP:0002920Decreased circulating ACTH level1PROP1 CL E G H56269455ORPHA:90695Non-acquired panhypopituitarismHP:0040282 - Frequent54
HP:0011043HP:0002920Decreased circulating ACTH level1SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0011043HP:0002920Decreased circulating ACTH level1SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0011043HP:0002920Decreased circulating ACTH level1SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0011043HP:0002920Decreased circulating ACTH level1SOX3 CL E G H665811199ORPHA:90695Non-acquired panhypopituitarismHP:0040282 - Frequent24
HP:0011043HP:0002920Decreased circulating ACTH level1SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0011043HP:0002920Decreased circulating ACTH level1TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0011043HP:0003154Increased circulating ACTH level1TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011043HP:0002920Decreased circulating ACTH level1TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0011043HP:0003154Increased circulating ACTH level1USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011043HP:0003154Increased circulating ACTH level1USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011043HP:0003154Increased circulating ACTH level1USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7


Genes (45) :AIP AKT1 ARMC5 ATRX BAP1 BRAF CDH23 CYP11A1 CYP11B1 DAXX FOXA2 GLI2 GNAS HESX1 LHX3 LHX4 MC2R MEN1 MRAP NF2 NFKB2 NNT NR3C1 OTX2 PDE11A PDE8B PDGFB PIK3CA POR POU1F1 PRKACA PRKAR1A PROP1 SMARCB1 SMARCE1 SMO SOX3 STAR SUFU TERT TP53 TRAF7 TXNRD2 USP48 USP8

Diseases (27) :OMIM:219090 ORPHA:2965 ORPHA:2495 OMIM:615954 ORPHA:189427 ORPHA:96253 ORPHA:100075 ORPHA:91347 ORPHA:168558 ORPHA:289548 ORPHA:90795 ORPHA:95494 OMIM:219080 ORPHA:226307 ORPHA:361 OMIM:202200 OMIM:607398 ORPHA:293978 ORPHA:786 OMIM:613986 OMIM:610475 ORPHA:189439 OMIM:201750 ORPHA:95699 OMIM:613571 OMIM:610489 ORPHA:90695
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.